Skip to main content
. 2020 May 20;8:198. doi: 10.3389/fpubh.2020.00198

Table 2.

Characteristic of patients with COVID-19 stratified by disease severity.

Variables Total (n = 115) Disease severity P-value
Non–severe (n = 93) Severe (n = 22)
Age, years 48.2 ± 17.4 47.0 ± 17.8 53.1 ± 15.5 0.145
Age, n (%)
    <60 years old 85 (73.9) 69 (74.2) 16 (72.7) 0.888
   ≥60 years old 30 (26.1) 24 (25.8) 6 (27.3)
Gender, n (%) 0.009
   Male 60 (52.2) 43 (46.2) 17 (77.3)
   Female 55 (47.8) 50 (53.8) 5 (22.7)
Wuhan-related exposure, n (%) 0.004
   Yes 22 (19.1) 13 (14.0) 9 (40.9)
   No 93 (80.9) 80 (86.0) 13 (59.1)
Time from onset to initial treatment, days 1.0 (0.0–4.0) 1.0 (0.0–4.0) 1.0 (0.3–3.0) 0.780
Time from onset to isolation, n (%)*
    ≤ 0 days 33 (29.2) 27 (29.4) 6 (28.6) 0.943
    ≤ 5 days 51 (45.1) 42 (45.6) 9 (42.8)
   >5 days 29 (25.7) 23 (25.0) 6 (28.6)
Time from onset to diagnosis, days 5.0 (2.0–8.5) 5.0 (2.3–8.0) 4.0 (1.5–9.5) 0.730
Time from onset to diagnosis, n (%)*
    ≤ 5 days 65 (57.5) 54 (58.7) 11 (52.4) 0.579
   >5 days 48 (42.5) 38 (41.3) 10 (47.6)
Source of transmission, n (%) 0.080
   Family or relatives 45 (39.1) 40 (43.0) 5 (22.7)
   Others 70 (60.9) 53 (57.0) 17 (77.3)
Fever, n (%) 0.284
   Yes 95 (82.6) 78 (83.9) 19 (86.4)
   No 16 (13.9) 12 (12.9) 1 (4.5)
   Unclear 4 (3.5) 3 (3.2) 2 (9.1)
Cough, n (%) 0.447
   Yes 24 (20.9) 19 (20.4) 5 (22.7)
   No 86 (74.8) 71 (76.4) 15 (68.2)
   Unclear 5 (4.3) 3 (3.2) 2 (9.1)
Fatigue, n (%) 0.346
   Yes 11 (9.5) 8 (8.6) 3 (13.6)
   No 99 (86.1) 82 (88.2) 17 (77.3)
   Unclear 5 (4.4) 3 (3.2) 2 (9.1)
Headache, n (%) 0.378
   Yes 10 (8.7) 9 (9.7) 1 (4.5)
   No 100 (87.0) 81 (87.1) 19 (86.4)
   Unclear 5 (4.3) 3 (3.2) 2 (9.1)
*

n = 2 missing data.